AmerisourceBergen earnings rise 6.1% in quarter

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p16
Trade Publication
The article reports on the corporate profit of AmerisourceBergen Corp. which increased by 6.1 percent to 160.5 million dollars in December 2010 in the U.S.


Related Articles

  • Supply chain, new drug therapies drive AmeriSource Bergen 1Q sales.  // Drug Store News;2/17/2003, Vol. 25 Issue 2, p32 

    Reports on the net earnings of drug wholesaler AmerisourceBergen in the U.S. Growth of the company revenue; Increase in pharmaceutical distribution; Factors contributing for the increase in the profit.

  • Profits expected to rise 8% to 12% in fiscal year.  // Chain Drug Review;7/16/2012, Vol. 34 Issue 12, p52 

    The article reports that profits earned by AmerisourceBergen Corp. in fiscal 2012 are expected to increase 8-12%.

  • Financial results top expectations in second quarter.  // Chain Drug Review;6/7/2010, Vol. 32 Issue 10, p61 

    The article reports on the increase in the earnings of AmerisourceBergen Corp. for the second quarter of 2010 which was facilitated by the sales of generic drugs and cost controls in the U.S.

  • Setting high expectations for performance. Tosh, Mark // Drug Store News;12/17/2001, Vol. 23 Issue 19, p46 

    Reports on the financial performance of AmerisourceBergin in 2001. Operating revenue posted by the company in the fourth quarter that ended September 30, 2001; Net income and earnings per share of the company for the year; Trading status of the company's stocks at the New York Stock Exchange.

  • Earnings advance 30.4% at AmerisourceBergen.  // Chain Drug Review;9/13/2010, Vol. 32 Issue 15, p16 

    The article reports on the 30.4% earning increase of AmerisourceBergen Corp. from its continuing operations on a 6.6% revenue gain in Valley Forge, Pennsylvania.

  • Outlook for balance of fiscal year raised.  // Chain Drug Review;9/13/2010, Vol. 32 Issue 15, p16 

    The article reports that Amerisource-Bergen Corp. has raised its earnings projection for 2010 to a range of 2.16 dollars to 2.20 dollars per diluted share in Valley Forge, Pennsylvania.

  • Double-digit profit growth forecast for '15.  // Chain Drug Review;12/8/2014, Vol. 36 Issue 20, p20 

    The article projects an increase in the 2015 earnings of drug wholesale company AmerisourceBergen Corp. due to its strategic alliance with drug chain Walgreen Co. and drug retail company Alliance Boots GmbH.

  • AMERISOURCEBERGEN CORP.  // MondayMorning;7/30/2012, p1 

    The article reports on the financial performance of Chesterbrook, Pennsylvania-based Amerisourcebergen Corp. as of the third quarter of 2012, with emphasis on its decreasing net income after losing a large retail customer.

  • AmerisourceBergen net up 11% in fiscal '10.  // Chain Drug Review;12/12/2011, Vol. 33 Issue 21, p19 

    The article reports on the increase in net income by 11 percent for fiscal 2010 at AmerisourceBergen Corp.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics